Benecke, Reiner <br/><br/>
Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections?  [electronic resource] 

 -  Pain medicine (Malden, Mass.)  Nov 2011 
 - 1607-14 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1526-4637 
<br/><br/><label>Standard No.: </label>10.1111/j.1526-4637.2011.01163.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Back Pain--drug therapy<br/>Botulinum Toxins, Type A--administration & dosage<br/>Cervical Vertebrae<br/>Double-Blind Method<br/>Humans<br/>Injections<br/>Male<br/>Middle Aged<br/>Muscles<br/>Myofascial Pain Syndromes--drug therapy<br/>Neuromuscular Agents--administration & dosage<br/>Pain Measurement<br/>Placebos<br/>Prospective Studies<br/>Shoulder<br/>Treatment Outcome<br/>Trigger Points